Home Tags Relapsed/Refractory Multiple Myeloma

Tag: Relapsed/Refractory Multiple Myeloma

ASCO 2022: Belantamab Mafodotin in the Treatment of Patients with Relapsed/Refractory...

The treatment patients diagnosed with relapsed or relapsed/refractory multiple myeloma (RRMM), those who have relapsed or who are refractory to at least 1 line of...

GSK2857916 Demonstrates 60% Response Rate in Heavily Pre-treated Relapsed/Refractory Multiple Myeloma...

The investigational BCMA antibody-drug conjugate GSK2857916, also known as J6M0-mcMMAF, recently awarded Breakthrough Therapy designation from the US Food and Drug Administration (FDA) and...

X